Home Healthcare Medical Devices Brachytherapy Market

Brachytherapy Market Size, Share & Trends Analysis Report By Dosage (High-dose Rate (HDR) Brachytherapy, Low-dose Rate (LDR) Brachytherapy), By Product (Seeds, Applicators & Afterloaders, Electronic Brachytherapy), By Applications (Prostate Cancer, Gynecological Cancer, Breast Cancer, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR6195DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Brachytherapy Market, By Dosage 2022-2034 (USD MILLION/ Units)
    1. High-dose Rate (HDR) Brachytherapy
    2. Low-dose Rate (LDR) Brachytherapy
  2. Brachytherapy Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Seeds
    2. Applicators & Afterloaders
    3. Electronic Brachytherapy
  3. Brachytherapy Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Prostate Cancer
    2. Gynecological Cancer
    3. Breast Cancer
    4. Others
  4. Regional Brachytherapy Market
    1. North America
      1. North America Brachytherapy Market By Dosage 2022-2034 (USD MILLION/ Units)
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
      2. North America Brachytherapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Seeds
        2. Applicators & Afterloaders
        3. Electronic Brachytherapy
      3. North America Brachytherapy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Gynecological Cancer
        3. Breast Cancer
        4. Others
      4. U.S.
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      5. Canada
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
    2. Europe
      1. Europe Brachytherapy Market By Dosage 2022-2034 (USD MILLION/ Units)
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
      2. Europe Brachytherapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Seeds
        2. Applicators & Afterloaders
        3. Electronic Brachytherapy
      3. Europe Brachytherapy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Gynecological Cancer
        3. Breast Cancer
        4. Others
      4. U.K.
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      5. Germany
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      6. France
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      7. Spain
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      8. Italy
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      9. Russia
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      10. Nordic
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      11. Benelux
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      12. Rest of Europe
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
    3. APAC
      1. APAC Brachytherapy Market By Dosage 2022-2034 (USD MILLION/ Units)
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
      2. APAC Brachytherapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Seeds
        2. Applicators & Afterloaders
        3. Electronic Brachytherapy
      3. APAC Brachytherapy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Gynecological Cancer
        3. Breast Cancer
        4. Others
      4. China
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      5. Korea
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      6. Japan
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      7. India
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      8. Australia
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      9. Singapore
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      10. Taiwan
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      11. South East Asia
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      12. Rest of Asia-Pacific
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
    4. Middle East and Africa
      1. Middle East and Africa Brachytherapy Market By Dosage 2022-2034 (USD MILLION/ Units)
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
      2. Middle East and Africa Brachytherapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Seeds
        2. Applicators & Afterloaders
        3. Electronic Brachytherapy
      3. Middle East and Africa Brachytherapy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Gynecological Cancer
        3. Breast Cancer
        4. Others
      4. UAE
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      5. Turkey
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      6. Saudi Arabia
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      7. South Africa
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      8. Egypt
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      9. Nigeria
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      10. Rest of MEA
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
    5. LATAM
      1. LATAM Brachytherapy Market By Dosage 2022-2034 (USD MILLION/ Units)
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
      2. LATAM Brachytherapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Seeds
        2. Applicators & Afterloaders
        3. Electronic Brachytherapy
      3. LATAM Brachytherapy Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Gynecological Cancer
        3. Breast Cancer
        4. Others
      4. Brazil
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      5. Mexico
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      6. Argentina
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      7. Chile
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      8. Colombia
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
      9. Rest of LATAM
        1. High-dose Rate (HDR) Brachytherapy
        2. Low-dose Rate (LDR) Brachytherapy
        3. Seeds
        4. Applicators & Afterloaders
        5. Electronic Brachytherapy
        6. Prostate Cancer
        7. Gynecological Cancer
        8. Breast Cancer
        9. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.